Skip to main content
TC

Thess Corp

Thess Corp provides two CE‑marked medical devices: Thess Device, a connected medication dispenser that securely stores multiple drug packages, supports up to nine fingerprint profiles, and transmits real‑time adherence data to clinicians; and Thess Monitoring, a tele‑surveillance platform that collects post‑surgical pain scores and kidney disease metrics and delivers encrypted data to care teams via a secure dashboard. Both solutions enable hospitals, surgical centers, and nephrology clinics to monitor medication compliance and patient condition remotely, with reimbursement under French social security.

Montpellier, FranceFounded 202019700+ followers
Updated 2 months ago

Funding

$5.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Patients on complex oral therapies often miss doses or take incorrect amounts, leading to reduced treatment efficacy and increased risk of complications. Clinicians also lack real-time visibility into medication adherence and post‑operative pain levels, making it difficult to intervene promptly and prevent chronic issues.

Solution

Thess offers two CE‑marked medical devices that address these gaps. Thess Device is a connected medication dispenser that securely stores multiple drug packages, enables remote dose adjustments, and authenticates each intake with up to nine fingerprint profiles. Data on each administration are transmitted in real time to a cloud platform, where clinicians can monitor adherence, receive alerts for missed doses, and intervene remotely. Thess Monitoring is a tele‑surveillance solution dedicated to post‑surgical pain and chronic kidney disease management; it collects patient‑reported pain scores and physiological parameters, encrypts the information, and delivers it to care teams via a secure dashboard. Both devices are interoperable, support international connectivity, and are reimbursable under French social security for nephrology applications.

Target Audience

Primary users are hospitals, surgical centers, and nephrology clinics that need to ensure medication adherence and monitor post‑operative pain, as well as home‑care providers and caregivers managing patients on complex oral regimens.

Features

  • Connected medication dispenser with multi‑compartment storage for several daily drugs
  • Remote, real‑time dose adjustment capability for clinicians
  • Fingerprint‑based unlocking (up to 9 profiles) to prevent unauthorized access
  • Up to one month of battery life under daily use
  • Automatic refill alerts and easy cartridge replacement mimicking traditional weekly pill boxes
  • Tele‑monitoring module for post‑operative pain (Thess Monitoring Antalgeek) with validated pain scoring
  • Certified for nephrology tele‑surveillance and covered by French health insurance
  • Secure, encrypted data transmission to a cloud analytics platform with clinician dashboards and alert configuration
This profile is AI-generated and may contain inaccuracies.